According to the researchers at the Washington University School of Medicine in St. Louis,
their particular study and research have shown that antibody-dependent enhancement (ADE) of infection is actually able to be suppressed by C1q, a blood-borne immune system compound.

Er, let�s put it on a more understandable context.

This epidemiological and laboratory-based ADE study is relevant in helping the control of viral disease outbreaks. Public health experts and clinicians may someday be able to design more effective aid systems such as safer and more effective vaccines.

The results of this study may also be the key to formulating a working dengue vaccine. Scientists have theorized that dengue patients become more vulnerable to another infection because of inadequate antibodies to eradicate the dengue virus when it returned. However, when researchers tried to simulate this particular phenomenon in animal models, they were unable to.

Source: Newswise